Latest disclosed trades
Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.
See the tradesUpdated Oct 17 · 1 feed behind: Insider filings, 2 days · Every feed →
MPLT · Insiders · $15K+ · 49 trades
Trades
49
Buys 6 · Sells 43
People
8
Stocks
1
Disclosed value
$78.2M
range midpoints · Congress & executive
Filed late
4
- ▼ SELLKristopher Hanson General CounselMPLT MapLight Therapeutics, Inc.$72.9Kdisclosed Oct 16 · filed 1 day after the trade
- ▼ SELLChristopher A. Kroeger Chief Executive OfficerMPLT MapLight Therapeutics, Inc.$595Kdisclosed Oct 16 · filed 1 day after the trade
- ▼ SELLJames Woodruff Lillie Chief Scientific OfficerMPLT MapLight Therapeutics, Inc.$93Kdisclosed Oct 16 · filed 1 day after the trade
- ▼ SELLJonathan Gillis CAO and Interim CFOMPLT MapLight Therapeutics, Inc.$82.1Kdisclosed Oct 16 · filed 1 day after the trade
- ▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$124Kdisclosed Oct 16 · filed 1 day after the trade
- ▼ SELLAnatol Kreitzer Chief Discovery OfficerMPLT MapLight Therapeutics, Inc.$96Kdisclosed Oct 16 · filed 1 day after the trade
- ▼ SELLKristopher Hanson General CounselMPLT MapLight Therapeutics, Inc.$193Kdisclosed Sep 18 · filed 2 days after the trade
- ▲ BUYCatalyst4, Inc. 10% ownerMPLT MapLight Therapeutics, Inc.$50.1Mdisclosed Aug 18 · filed 4 days after the trade
- ▼ SELLJames Woodruff Lillie Chief Scientific OfficerMPLT MapLight Therapeutics, Inc.$277Kdisclosed Aug 4 · filed 1 day after the trade
- ▲ BUYCatalyst4, Inc. 10% ownerMPLT MapLight Therapeutics, Inc.$37.9Kdisclosed Jul 30 · filed 1 day after the trade
- ▲ BUYCatalyst4, Inc. 10% ownerMPLT MapLight Therapeutics, Inc.$1.5Mdisclosed Jul 30 · filed 2 days after the trade
- ▲ BUYCatalyst4, Inc. 10% ownerMPLT MapLight Therapeutics, Inc.$761Kdisclosed Jul 30 · filed 2 days after the trade
- ▲ BUYCatalyst4, Inc. 10% ownerMPLT MapLight Therapeutics, Inc.$13Mdisclosed Jul 30 · filed the same day
- ▲ BUYTroy Cox DirectorMPLT MapLight Therapeutics, Inc.$149Kdisclosed Jul 28 · filed the same day
- ▼ SELLJonathan Gillis CAO and Interim CFOMPLT MapLight Therapeutics, Inc.$34.4Kdisclosed Jul 20 · filed 3 days after the trade
- ▼ SELLAnatol Kreitzer Chief Discovery OfficerMPLT MapLight Therapeutics, Inc.$59.6Kdisclosed Jul 20 · filed 4 days after the trade
- ▼ SELLJonathan Gillis CAO and Interim CFOMPLT MapLight Therapeutics, Inc.$638Kdisclosed Jul 20 · filed 3 days after the trade
- ▼ SELLAnatol Kreitzer Chief Discovery OfficerMPLT MapLight Therapeutics, Inc.$533Kdisclosed Jul 20 · filed 3 days after the trade
- ▼ SELLAnatol Kreitzer Chief Discovery OfficerMPLT MapLight Therapeutics, Inc.$274Kdisclosed Jul 20 · filed 4 days after the trade
- ▼ SELLJonathan Gillis CAO and Interim CFOMPLT MapLight Therapeutics, Inc.$55.3Kdisclosed Jul 20 · filed 4 days after the trade
- ▼ SELLAnatol Kreitzer Chief Discovery OfficerMPLT MapLight Therapeutics, Inc.$167Kdisclosed Jul 20 · filed 5 days after the trade · late
- ▼ SELLAnatol Kreitzer Chief Discovery OfficerMPLT MapLight Therapeutics, Inc.$105Kdisclosed Jul 20 · filed 3 days after the trade
- ▼ SELLJonathan Gillis CAO and Interim CFOMPLT MapLight Therapeutics, Inc.$21.9Kdisclosed Jul 20 · filed 3 days after the trade
- ▼ SELLJonathan Gillis CAO and Interim CFOMPLT MapLight Therapeutics, Inc.$174Kdisclosed Jul 20 · filed 5 days after the trade · late
- ▼ SELLJonathan Gillis CAO and Interim CFOMPLT MapLight Therapeutics, Inc.$194Kdisclosed Jul 20 · filed 5 days after the trade · late